Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
British Journal of Haematology|May 1, 1985
Graft-versus-host disease prophylaxis with anti-T-cell monoclonal antibody OKT3, prednisone and methotrexate in allogeneic bone-marrow transplantationA H Filipovich, C L Krawczak, J H Kersey, et al.
Blood|April 1, 1986
Cytomegalovirus infection after bone marrow transplantation: an association with acute graft-v-host diseaseW Miller, P Flynn, J McCullough, et al.
Blood|November 8, 2001
Effect of HLA class II gene disparity on clinical outcome in unrelated donor hematopoietic cell transplantation for chronic myeloid leukemia: the US National Marrow Donor Program ExperienceE W Petersdorf, C Kollman, C K Hurley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1987
Therapy of chronic myelogenous leukemia with allogeneic bone marrow transplantationP McGlave, D Arthur, R Haake, et al.
Blood|September 1, 1985
Autologous bone marrow transplantation for patients with acute lymphoblastic leukemia in second or subsequent remission: results of bone marrow treated with monoclonal antibodies BA-1, BA-2, and BA-3 plus complementN Ramsay, T LeBien, M Nesbit, et al.
Seminars in Hematology|October 1, 1993
Donor and host influences in bone marrow transplantation for immunodeficiency disease and leukemiaJ Kersey, A Filipovich, P McGlave, et al.
Infection Control : IC|March 1, 1983
A prospective study of infectious diseases following bone marrow transplantation: emergence of Aspergillus and Cytomegalovirus as the major causes of mortalityP K Peterson, P McGlave, N K Ramsay, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 7, 2000
A randomized trial comparing prednisone with antithymocyte globulin/prednisone as an initial systemic therapy for moderately severe acute graft-versus-host diseaseL Cragg, B R Blazar, T Defor, et al.
Blood|September 1, 1983
Total lymphoid irradiation and cyclophosphamide conditioning prior to bone marrow transplantation for patients with severe aplastic anemiaN K Ramsay, T H Kim, P McGlave, et al.
Bone Marrow Transplantation|March 20, 1999
B cell lymphoproliferative disorders following hematopoietic stem cell transplantation: risk factors, treatment and outcomeT G Gross, M Steinbuch, T DeFor, et al.
Pageof 7